BioNTech SE (BNTX) Total Current Liabilities (2018 - 2025)

BioNTech SE (BNTX) has 8 years of Total Current Liabilities data on file, last reported at $2.5 billion in Q4 2025.

• For the quarter ending Q4 2025, Total Current Liabilities fell 7.51% year-over-year to $2.5 billion; the trailing twelve-month figure through Dec 2025 stood at $2.5 billion (down 7.51% YoY), and the FY2025 full-year result was $2.4 billion, down 10.23% from the prior year.
• Total Current Liabilities retreated to $2.5 billion in Q4 2025, from $2.6 billion in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $5.8 billion in Q3 2021 to a low of $1.6 billion in Q1 2021.
• A 5-year average of $2.9 billion and a median of $2.6 billion in 2025 frame the typical range for Total Current Liabilities.
• Across the five-year window, Total Current Liabilities jumped 1743.58% in 2021 and sank 61.52% in 2023, its largest moves.
• Tracing BNTX's Total Current Liabilities over 5 years: stood at $4.0 billion in 2021, then retreated by 24.42% to $3.0 billion in 2022, then slipped by 26.0% to $2.2 billion in 2023, then advanced by 21.03% to $2.7 billion in 2024, then dropped by 7.51% to $2.5 billion in 2025.
• Business Quant data shows BNTX's Total Current Liabilities at $2.5 billion in Q4 2025, $2.6 billion in Q3 2025, and $2.1 billion in Q2 2025.